Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Iron chelator.
BRD2/3/4 inhibitor.
Histamine H1 antagonist.
Neuroprotective flavonoid
NSAID; COX-1/2 inhibitor.
Abl, c-Kit, PDGFR inhibitor.
HDAC inhibitor.
Thienylbutyl ITC analog.
Induces cardiomyogenic effects in pluripotent c...
Oligodendrocyte antigen used to induce EAE.
Mycotoxin produced by Fusarium fungi that infec...
Analog of staurosporine.
CDK4/6 inhibitor.
Cyclic depsipeptide is a secondary metabolite i...
Corticosteroid
Natriuretic, vasodilatory peptide fragment; B1/...
ATP competitive CDK inhibitor.
CDK2 inhibitor.
Sesquiterpene lactone found in Artemisia (wormw...
Taxane synthesis intermediate.